marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2025-Q2
added 08-13-2025
Aethlon Medical Net Income 2011-2025 | AEMD
Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.
Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]
It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.
The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.
Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.
It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.
However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.
Annual Net Income Aethlon Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13.4 M | -12.2 M | -12 M | -10.4 M | -7.89 M | -6.37 M | -6.19 M | -5.68 M | -7.28 M | -4.87 M | -6.8 M | -13.4 M | -4.89 M | -8.11 M | -5.71 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -4.87 M | -13.4 M | -8.35 M |
Quarterly Net Income Aethlon Medical
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.76 M | - | -1.75 M | -2.81 M | -2.57 M | - | -3.47 M | -3.03 M | -3.28 M | - | -2.85 M | -3.81 M | -2.91 M | - | -2.53 M | -6.63 M | -2.1 M | - | -2.44 M | -5.62 M | -1.77 M | -1.41 M | -820 K | -820 K | -1.71 M | -2.07 M | -2.01 M | -2.01 M | -1.39 M | - | -1.22 M | -1.3 M | -1.84 M | - | -1.21 M | -5.59 M | -4.38 M | - | -1.22 M | -3.62 M | -2.41 M | - | -1.55 M | -5.91 M | -4.5 M | - | -2.23 M | -5.88 M | -3.65 M | - | 314 K | -2.13 M | -2.44 M | - | -575 K | -3.61 M | -3.04 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 314 K | -6.63 M | -2.66 M |
References
- Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.
Net Income of other stocks in the Medical devices industry
| Issuer | Net Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Dynatronics Corporation
DYNT
|
-10.9 M | $ 0.24 | 14.99 % | $ 929 K |  USA |
 |
Aziyo Biologics
AZYO
|
-37.7 M | $ 1.48 | 1.37 % | $ 20.5 M | USA |
 |
Natus Medical Incorporated
NTUS
|
13.2 M | $ 31.08 | 1.94 % | $ 1.05 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-12.3 M | $ 3.05 | -5.86 % | $ 30.6 M | USA |
 |
Cardiovascular Systems
CSII
|
-36.9 M | $ 20.0 | 0.15 % | $ 844 M | USA |
 |
Neovasc
NVCN
|
-24.9 M | $ 30.03 | - | $ 111 M |  Canada |
 |
Apollo Endosurgery
APEN
|
-39.8 M | $ 10.0 | - | $ 475 M | USA |
 |
Titan Medical
TMDI
|
-14.9 M | $ 0.14 | -26.32 % | $ 19.6 M | Canada |
 |
Insulet Corporation
PODD
|
418 M | $ 320.45 | 2.38 % | $ 22.5 B | USA |
 |
Viveve Medical
VIVE
|
-22 M | $ 0.22 | -15.35 % | $ 1.71 M | USA |
 |
Invacare Corporation
IVC
|
-20.6 M | $ 0.66 | - | $ 24.7 M | USA |
 |
Quanterix Corporation
QTRX
|
-32.3 M | $ 5.33 | -0.28 % | $ 200 M | USA |
 |
Abiomed
ABMD
|
226 M | $ 381.02 | - | $ 17.2 B | USA |
 |
AVITA Medical
RCEL
|
-61.8 M | $ 3.76 | -2.84 % | $ 97.3 M |  Australia |
 |
Allied Healthcare Products
AHPI
|
-1.94 M | $ 0.55 | 3.58 % | $ 2.21 M | USA |
 |
CryoLife, Inc.
CRY
|
-16.7 M | $ 17.84 | -4.14 % | $ 702 M | USA |
 |
Sintx Technologies
SINT
|
-8.26 M | $ 3.33 | 4.62 % | $ 12.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-18.6 M | $ 24.04 | - | $ 1.77 B | USA |
 |
Soliton, Inc.
SOLY
|
-14.5 M | $ 20.12 | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-9.14 K | $ 10.38 | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-10.9 M | $ 30.65 | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-17.4 M | $ 26.54 | - | $ 462 M | USA |
 |
ShockWave Medical
SWAV
|
147 M | $ 334.75 | - | $ 12.3 B | USA |
 |
SeaSpine Holdings Corporation
SPNE
|
-54.3 M | $ 7.16 | 0.28 % | $ 270 M | USA |
 |
ViewRay
VRAY
|
-107 M | $ 2.64 | 1.54 % | $ 468 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-72.3 M | $ 28.24 | - | $ 955 M | USA |
 |
Bruker Corporation
BRKR
|
113 M | $ 38.83 | -0.3 % | $ 5.79 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-59.7 M | $ 70.98 | - | $ 3.31 B | USA |
 |
BIOLASE
BIOL
|
-20.6 M | $ 0.13 | -13.19 % | $ 166 K | USA |
 |
Integer Holdings Corporation
ITGR
|
120 M | $ 66.39 | 2.87 % | $ 2.23 B | USA |
 |
Eargo
EAR
|
-157 M | $ 2.57 | - | $ 10.2 M | USA |
 |
Delcath Systems
DCTH
|
-26.4 M | $ 9.5 | -3.36 % | $ 271 M | USA |
 |
Viemed Healthcare
VMD
|
10.2 M | $ 6.55 | 1.39 % | $ 251 M | USA |
 |
SmileDirectClub
SDC
|
-86.4 M | $ 0.08 | -53.45 % | $ 9.71 M | USA |
 |
Globus Medical
GMED
|
103 M | $ 60.86 | 0.78 % | $ 8.26 B | USA |
 |
ThermoGenesis Holdings
THMO
|
-11.8 M | $ 0.31 | -25.84 % | $ 171 K | USA |
 |
Acutus Medical
AFIB
|
-81.7 M | $ 0.09 | -26.83 % | $ 2.62 M | USA |
 |
ClearPoint Neuro
CLPT
|
-18.9 M | $ 19.02 | -18.07 % | $ 514 M | USA |
 |
Surgalign Holdings
SRGA
|
-54.6 M | $ 0.18 | -32.98 % | $ 1.68 M | USA |
 |
Conformis
CFMS
|
-50.5 M | $ 2.27 | - | $ 16.4 M | USA |
 |
Sientra
SIEN
|
-62.5 M | $ 0.18 | -16.59 % | $ 10.3 M | USA |
 |
NuVasive
NUVA
|
40.4 M | $ 39.75 | - | $ 2.07 B | USA |
 |
Cutera
CUTR
|
-57.2 M | $ 0.1 | -10.19 % | $ 1.99 M | USA |
 |
Nemaura Medical
NMRD
|
-14.1 M | $ 0.11 | -17.8 % | $ 2.74 M |  Britain |
 |
Vapotherm
VAPO
|
-58.2 M | $ 1.27 | 6.72 % | $ 34 M | USA |
 |
Beyond Air
XAIR
|
-46.6 M | $ 1.94 | -5.83 % | $ 131 M | USA |
 |
Xtant Medical Holdings
XTNT
|
-16.4 M | $ 0.82 | -6.71 % | $ 110 M | USA |
 |
Pulmonx Corporation
LUNG
|
-56.4 M | $ 1.81 | -9.5 % | $ 70.8 M | USA |